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ABSTRACT
Background: Microscopic polyangiitis is a vasculitic disease that may result in a pulmonary renal syndrome.
Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis is strongly associated with infection.
Case Summary: We describe a case of microscopic polyangiitis that developed in a patient with MPO-ANCA
positive pulmonary fibrosis following infection with mycoplasma. A renal biopsy was undertaken following the
detection of microscopic hematuria during follow-up but no abnormal findings were evident. The MPO-ANCA
titer increased following infection with mycoplasma pneumonia and a second renal biopsy demonstrated cres-
centic glomerulonephritis. The degree of pulmonary fibrosis was unaffected.
Discussion: The present case suggests that the mycoplasma infection triggered the elevation of MPO-ANCA
titer and provoked glomerulonephritis in a patient with MPO-ANCA positive IPF. This case indicates the impor-
tance of testing for MPO-ANCA at the time of initial diagnosis, performing urinalysis and examining the urine
sediment during follow-up and being alert to the potential onset of vasculitis in cases of pulmonary fibrosis.
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INTRODUCTION
Myeloperoxidase anti-neutrophil cytoplasmic autoan-
tibody (MPO-ANCA) is frequently positive in patients
with microscopic polyangiitis and allergic granuloma-
tous angiitis (Churg-Strauss syndrome). In addition,
the clinical course of MPO-ANCA positive patients is
frequently complicated with lung involvement such
as interstitial pneumonia or alveolar hemorrhage.1
We report a case of microscopic polyangiitis (MPA)
that developed after mycoplasma infection in a 47-
year-old woman with a history of MPO-ANCA positive
pulmonary fibrosis. To our knowledge, cases of MPA
triggered by mycoplasma pneumonia have not been
previously described.
CASE REPORT
A 47-year-old woman with a one-year history of a dry
cough was referred to our hospital in September
1995. The chest X-ray showed bilateral reticular shad-
owing affecting the lower lung fields. She was a non-
smoker and had no history of occupational inhalation
of stone dust. She was hospitalized for detailed ex-
amination but, despite numerous investigations, the
etiology of the lung fibrosis was not determined. She
was in a stable condition at that time and was there-
fore followed up without therapy being initiated. How-
ever, she later presented with shortness of breath on
exertion (Hugh- Johns II°) since October 2004 and
was admitted to hospital for further investigations in
April 2005.
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Fig.　1　a: Chest X-ray fi lm obtained upon admission in April 2005 showing the volume loss and 
reticular shadows especially in the lower lung fi elds. b, c: Chest CT scan shows volume loss of 
both lower lobes and reticular shadows with honeycomb changes especially in the two lower 
lobes.
Fig.　2　a: Pathological fi ndings of the 1st renal biopsy. There were no special fi ndings. b: Patho-
logical fi ndings of the 2nd renal biopsy. Necrotising glomerulonephritis with crescent formation 
and proliferation of cells and vessels were detected (H&E staining, original magnifi cation ×400).
A physical examination of the chest on admission
revealed bilateral inspiratory fine crackles in the mid-
dle and lower zones with no peripheral clubbing evi-
dent. The oxygen saturation was 96% and she was
afebrile. The chest X-ray film obtained on admission
showed reticular shadows and loss of volume espe-
cially affecting the lower lung fields (Fig. 1a). Chest
computed tomography (CT) showed volume loss of
the lower lobes and reticular shadows with honey-
comb changes especially in the lower lobes (Fig. 1b,
1c). Urinalysis was unremarkable at the time of ad-
mission.
The results of respiratory function tests were as fol-
lows: vital capacity (VC) 1.74 L (64.2% predicted),
forced expiratory volume in one second (FEV1) 1.48
L (60.4% predicted), residual volume (RV) 1.86 L
(78.7% predicted), total lung capacity 2.72 L (63.1%
predicted), carbon monoxide diffusing capacity of the
lung 12.07 mlminmmHg (53.5% predicted).
Arterial blood gas analysis on room air revealed
normal values: PaO2 90.4 Torr and PaCO2 43.6 Torr.
Peripheral blood tests were as follows: C-reactive pro-
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Fig.　3　a, b, c: The course of the chest CT after mycoplas-
ma infection. Lung fi brosis had not changed.
tein 0.2 mgdl with normal serum electrolytes, renal
function and liver function. Notable laboratory values
included the following: serum KL-6 601 Uμl (normal:
<500 Uμl); SP-D 100 ngml (normal: <110 ngml);
SP-A 35.4 ngml (normal <43.8 ngml); IgG 2530
mgdl; positive anti-nuclear antibody (1 in 80, speck-
led type); MPO-ANCA increased at 158 EU (normal
range; <10.0 EU). A bronchoscopy with bronchoal-
veolar lavage was performed through the right S8
bronchus and revealed a slight increase in neutro-
phils: 4.3 × 105 cellsml (macrophages 74.3%, lympho-
cytes 5%, neutrophils 5%, eosinophils 1.2%). She was
reviewed by our Nephrology colleagues in view of the
positive MPO-ANCA. It was felt that there was no in-
dication for a renal biopsy and recommended that uri-
nalysis should be monitored. Microscopic hematuria
first appeared a month after discharge from hospital
although she had no symptoms. A renal biopsy was
performed in July 2005 (Fig. 2a) but there were no
specific findings.
She was incidentally hospitalized with a bone frac-
ture in August 2006. Prior to discharge she experi-
enced a high fever and dry cough and the PaO2 on
blood gas dropped to 62.2 Torr. Consolidation in the
right S2 was detected on the chest CT (Fig. 3a) and
the mycoplasma IgM was positive. She was subse-
quently diagnosed with a mycoplasma pneumonia.
Treatment consisted of 400 mg gatifoxacine per day.
The dry cough and hypoxia promptly recovered and
the consolidation in right S2 on chest CT improved.
However, the patient remained febrile (38-39℃) and
the CRP level remained high. The urinary β2 mi-
croglobulin increased from 857 μgl to 8062 μgl and
the MPO-ANCA titer increased from 83 EU to 379
EU. Proteinuria then appeared, although it was very
slight. We thought that this might represent the on-
set of glomerulonephritis.
The patient was transferred to the Department of
Nephrology in October 2006 and a second renal bi-
opsy was performed. The biopsy demonstrated a ne-
crotising glomerulonephritis with crescent formation
and cellular proliferation (Fig. 2b). The clinical mani-
festations of vasculitis other than glomerulonephritis
were scarce with no involvement of the skin, nervous
system or gastrointestinal tract evident. The first 3-
day pulse of methylprednisolone (m-PSL) was com-
menced on October 11 and the 2nd pulse of m-PSL
was administered a week later. Oral prednisolone
(PSL) therapy (40 mgday) was started at the same
time. Pulsed cyclophosphamide was added on No-
vember 2. The fever and inflammation was promptly
relieved. The urinary abnormalities normalized 2
weeks after treatment with a reduced urinary level of
β2 microglobulin. In addition, the titer of MPO-ANCA
promptly fell from 379 IUml to 77 IUml after 1
month of treatment.
The PSL was tapered to 5 mg per day and she visits
our hospital regularly for follow-up. There has been
no change in the serum levels of KL-6 and SP-D and
the chest CT findings remained unchanged indicat-
ing no progression in the degree of lung fibrosis (Fig.
3b, 3c).
DISCUSSION
Infection has been suggested as a trigger of ANCA-
associated glomerulonephritis since the discovery of
ANCA. The first report concerning ANCA-associated
necrotising glomerulonephritis was in 19822 with
Ross River virus (a group A Arbovirus) being sug-
gested as a potential cause of ANCA-associated ne-
phritis. A variety of cases involving ANCA and infec-
tion have been reported such as ANCA-associated
mPA following a wound infection,3 mPA triggered by
fungal infection4 and mPA associated with E Coli
pyelonephritis.5 It was also suggested that acute or
chronic Chlamydia pneumoniae infection may in-
crease the risk of MPO-ANCA associated glomeru-
lonephritis.6
Nada et al.7 described two patients with an initial
diagnosis of idiopathic pulmonary fibrosis who were
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later correctly diagnosed as having a pulmonary-renal
syndrome and microscopic polyarteritis. Review of
the two lung biopsy specimens demonstrated a small-
vessel vasculitis. These cases illustrate the necessity
to consider vasculitis in the differential diagnosis of
idiopathic pulmonary fibrosis as it can occur as a fea-
ture of microscopic polyarteritis.
This would suggest that repetitive MPO-ANCA in-
duced damage to the alveolar microvascular endothe-
lium may cause pulmonary fibrosis. In addition, TNF-
α and IL-6 were detected in the sera in parallel with
the MPO-ANCA titers.8 This suggests that MPO-
ANCA antibodies and inflammatory cytokine such as
TNF-α and IL-6 induced by the infection may activate
neutrophils. MPO can be released from neutrophils
and may play an important pathogenic role in
glomerular capillary necrosis leading to crescentic
glomerulonephritis. The amount of MPO proved to
be especially high in the cellular crescent phase of
disease and correlated with anti-MPO antibodies.9
In the present case, it is unclear exactly when the
patient MPO-ANCA became positive. The pulmonary
fibrosis preceded the development of microscopic he-
maturia by more than 10 years. It is also difficult to di-
agnose when the kidney disease first occurred. The
hematuria might be a warning sign and the myco-
plasma infection could have activated the ANCA-
associated vasculitis. We should have considered a
mycoplasma pneumoniae-associated glomeruloneph-
ritis in the differential diagnosis. There are some re-
ports of Mycoplasma pneumoniae-associated renal
disease such as cresescentic glomerulonephritis10,11
or IgA nephropathy.12 The MPO-ANCA was negative
in these cases. Determining the level of ANCA might
be useful in the differentiation of kidney disease that
may follow mycoplasma infection.
This case can be ANCA-associated nephritis with
preceding pulmonary fibrosis. Mycoplasma infection
could trigger an elevation of MPO-ANCA level and
lead to glomerulonephritis. We suggest that it is nec-
essary to examine MPO-ANCA at the time of the in-
itial diagnosis, to monitor urinalysis and the urine
sediment during follow-up and to be alert to the possi-
bility of vasculitis in cases of pulmonary fibrosis.
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